Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | CCR1 | P32246 | 1/20 | 0.32 |
| ▸ | CCR5 | P51681 | 1/20 | 0.32 |
| ▸ | CCR8 | P51685 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.32 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.32 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.32 |
| ▸ | NOS3 | P29474 | 2/20 | 0.31 |
| ▸ | NOS2 | P35228 | 2/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27342160 | 0.79 | NOS3 (0.36) | NOS3NOS2NOS1 | |
| SCHEMBL20049863 | 0.74 | KCNA5 (0.35) | — | |
| SCHEMBL101583 | 0.74 | CCR1 (0.50) | ESR1ESR2CCR1CCR5CCR8 | |
| SCHEMBL26169740 | 0.74 | ESR1 (0.43) | ESR1ESR2CCR1CCR5CCR8 | |
| SCHEMBL12749938 | 0.73 | NOS3 (0.55) | NOS3NOS2NOS1 | |
| SCHEMBL17827999 | 0.71 | CCR1 (0.43) | ESR1ESR2CCR1CCR5CCR8 | |
| SCHEMBL12692496 | 0.71 | CCR1 (0.43) | ESR1ESR2CCR1CCR5CCR8 | |
| SCHEMBL19919593 | 0.71 | ESR1 (0.37) | ESR1ESR2CCR1CCR5CCR8 | |
| SCHEMBL17827996 | 0.70 | CCR1 (0.41) | ESR1ESR2CCR1CCR5CCR8 | |
| SCHEMBL17827985 | 0.70 | ESR1 (0.43) | ESR1ESR2CCR1CCR5CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023078413-A1 | FGFR2 INHIBITOR, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF | 微境生物医药科技(上海)有限公司 | 2023-05-11 | — | — | WO | disclosed |